Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

BACKGROUND: A combination of safety concerns and labeling changes impacted use of erythropoiesis-stimulating agents (ESAs) in renal anemia. Data regarding contemporary utilization in pre-dialysis chronic kidney disease (CKD) are lacking. METHODS: Electronic healthcare records and medical claims data...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Nephrol
Egile Nagusiak: Stirnadel-Farrant, Heide A., Luo, Jiacong, Kler, Lata, Cizman, Borut, Jones, Delyth, Brunelli, Steven M., Cobitz, Alexander R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5996482/
https://ncbi.nlm.nih.gov/pubmed/29890958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-0925-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak